Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Queensland Health
Deloitte
Harvard Business School
Mallinckrodt
Daiichi Sankyo
Argus Health
Dow
Cerilliant

Generated: July 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020832

« Back to Dashboard

NDA 020832 describes CHLORAPREP WITH TINT, which is a drug marketed by Becton Dickinson Co and is included in one NDA. It is available from one supplier. There are six patents protecting this drug. Additional details are available on the CHLORAPREP WITH TINT profile page.

The generic ingredient in CHLORAPREP WITH TINT is chlorhexidine gluconate; isopropyl alcohol. There are fifty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.
Summary for 020832
Tradename:CHLORAPREP WITH TINT
Applicant:Becton Dickinson Co
Ingredient:chlorhexidine gluconate; isopropyl alcohol
Patents:6
Formulation / Manufacturing:see details
Generic Entry Opportunity Date for 020832
Generic Entry Date for 020832*:
Constraining patent/regulatory exclusivity:
Dosage::
SPONGE;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Suppliers and Packaging for NDA: 020832
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832 NDA CareFusion 213 LLC 54365-400 N 54365-400-07
CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832 NDA CareFusion 213 LLC 54365-400 N 54365-400-08

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SPONGE;TOPICALStrength2%;70% (3ML)
Approval Date:Jul 14, 2000TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Nov 10, 2020Product Flag?YSubstance Flag?Delist Request?

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SPONGE;TOPICALStrength2%;70% (26ML)
Approval Date:May 3, 2005TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Mar 14, 2023Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Jan 31, 2024Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 020832

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Becton Dickinson Co CHLORAPREP ONE-STEP FREPP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-003 Apr 26, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-007 Oct 10, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-001 Jul 14, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-001 Jul 14, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Deloitte
AstraZeneca
Merck
Teva
Mallinckrodt
Cipla
Chinese Patent Office
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.